Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(6)
Decitabine
1 trial
phase_2
md-anderson-cancer-center
sapacitabine and decitabine (Part 1 - completed)
1 trial
phase_1_2
cyclacel-pharmaceuticals-inc
Dasatinib (BMS-354825)
1 trial
phase_2
md-anderson-cancer-center
sapacitabine and venetoclax (Part 2 - recruiting)
1 trial
phase_1_2
cyclacel-pharmaceuticals-inc
Sapacitabine, Arm A
1 trial
phase_2
cyclacel-pharmaceuticals-inc
clofarabine
1 trial
phase_2
university-of-texas
6 unique interventions1 categories

Analytics

Trial Phases

Phase 11
Phase 25

Trial Status

Completed4
Other1

Role Distribution

Principal Investigator3
Other Roles2
PI Rate60%

Activity Timeline

Clinical Trials (5)

NCT01211457Phase 1/2Unknown
Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
Acute Myeloid LeukemiaMyelodysplastic Syndromes
StudychairStart date: 2010-06-17
NCT00590187Phase 2Completed
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Acute Myeloid Leukemia
StudychairStart date: 2007-12-01
NCT00255346Phase 2Completed
Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
Acute Myeloid LeukemiaAgnogenic Myeloid MetaplasiaHypereosinophilic Syndrome+5 more
PrincipalinvestigatorStart date: 2005-11-15
NCT00067808Phase 2Completed
Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)
Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
Principalinvestigator
NCT00098033Phase 2Completed
Investigation of Clofarabine in Acute Leukemias
Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia
Principalinvestigator

Research Network

Collaboration Network

26 collaborators·25 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jorge E Cortes, MD

M.D. Anderson Cancer Center

Moderately Similar
8 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more

Worked with same sponsors:

M.D. Anderson Cancer CenterUniversity of Texas
Collaborated on 1 trial
Similarity Score44%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+3 more

Worked with same sponsors:

Bristol-Myers SquibbM.D. Anderson Cancer Center
Similarity Score18%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myelomonocytic, Chronic+2 more
Similarity Score15%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+1 more
Similarity Score12%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more
Similarity Score12%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more
Similarity Score12%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute+1 more
Similarity Score12%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, Acute+1 more
Similarity Score12%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL Positive+1 more
Similarity Score12%

Farhad Ravandi-Kashani, MD

M.D. Anderson Cancer Center

Related
14 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

Bristol-Myers SquibbEisai Inc.+1 more
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT01211457Phase 1/2StudyChair

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

Acute Myeloid LeukemiaMyelodysplastic Syndromes
Unknown
NCT00590187Phase 2StudyChair

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Acute Myeloid Leukemia
Completed
NCT00255346Phase 2PrincipalInvestigator

Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

Acute Myeloid LeukemiaAgnogenic Myeloid MetaplasiaHypereosinophilic Syndrome+5 more
Completed
NCT00067808Phase 2PrincipalInvestigator

Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)

Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
Completed
NCT00098033Phase 2PrincipalInvestigator

Investigation of Clofarabine in Acute Leukemias

Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia
Completed

All 5 trials loaded